IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $105,889 | +11.0% | 15,041 | -3.6% | 0.00% | +33.3% |
| Q1 2023 | $95,371 | -7.5% | 15,609 | -3.3% | 0.00% | -25.0% |
| Q4 2022 | $103,115 | -41.4% | 16,137 | -12.3% | 0.00% | -50.0% |
| Q3 2022 | $176,000 | -25.4% | 18,394 | -6.5% | 0.01% | -20.0% |
| Q2 2022 | $236,000 | -32.2% | 19,668 | -0.5% | 0.01% | -23.1% |
| Q1 2022 | $348,000 | +17.6% | 19,766 | 0.0% | 0.01% | +18.2% |
| Q4 2021 | $296,000 | -43.1% | 19,766 | -0.7% | 0.01% | -52.2% |
| Q3 2021 | $520,000 | +19.0% | 19,896 | +21.4% | 0.02% | +9.5% |
| Q2 2021 | $437,000 | – | 16,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |